Moreover, our investigation of single-cell RNA datasets revealed that tumor cells expressing high levels of PLOD2 and SAA1 exhibited enhanced malignancy, as indicated by elevated MECRGS scores, stemness, and copy number variations (CNVs). The gene discussed is PLOD2; the disease is neoplasm.